The telehealth boom is healthier than ever.
In fact, according to Technavio, telehealth could become a $109.98 billion market by 2025.
Most of that will be driven by increased care needs for chronic diseases, such as cardiovascular issues, cancer, Alzheimer’s disease, asthma, and diabetes to name a few. That could be beneficial for companies such as Datametrex AI Limited (TSXV: DM) (OTCQB: DTMXF), Teladoc Health Inc. (NYSE: TDOC), WELL Health Technologies Corp. (TSX: WELL) (OTC: WHTCF), Doximity Inc. (NYSE: DOCS), and Uphealth Inc. (NYSE: UPH).
In addition, according to a CVS Health 2022 Health Care Insights Study, “A little over half (53 percent) of providers said that the addition of virtual care options led to an increase in patient visits, according to a new report. Compared to in-person appointments, healthcare consumers find virtual visits more convenient because they don’t have to leave home (41 percent), they don’t have to cover transportation costs (37 percent), and they save time (37 percent). Three, as also noted by the AMA, “Telehealth is critical to the future of health care, which is why the AMA continues to lead the charge to aggressively expand telehealth policy, research and resources to ensure physician practice sustainability and fair payment.”